AGLAIA BIOMEDICAL VENTURES
Aglaia is founded on the principle that the willingness to take risks on the very early stage ventures of today results in opportunities that may grow into the winning companies of tomorrow. As such, we are typically the first provider of capital for startup and early stage companies and a driving force behind product development. Since the number of technological discoveries in the biomedical field is growing fast, specialized knowledge regarding the translation of these discoveries into no... vel products is a prerequisite for success. Aglaia's focus on oncology is considered to be a differentiating asset. We invest in novel tools and technologies as well as components of contemporary drug development. Opportunities may be derived from research centers as well as from corporate spinouts. We select, develop and commercialize promising technologies up to a level where the technology becomes attractive to larger investors or pharmaceutical and biotech companies.
AGLAIA BIOMEDICAL VENTURES
Social Links:
Founded:
2003-01-01
Status:
Active
Contact:
+31 30 229 6090
Email Addresses:
[email protected]
Technology used in webpage:
SPF Microsoft Exchange Online Office 365 Mail Pound Sterling Dutch Server Location
Similar Organizations
TMT Investments
TMT Investments provides investors with liquid exposure to a diversified portfolio of earlier-stage technology startups.
VerteOZ
Verte Opportunity Fund invests in high-growth start-ups and speed-ups impacting opportunity zones.
Current Advisors List
Current Employees Featured
Founder
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2021-10-07 | Sapreme Technologies | Aglaia BioMedical Ventures investment in Series A - Sapreme Technologies | 15 M EUR |
| 2021-02-09 | InteRNA Technologies | Aglaia BioMedical Ventures investment in Series B - InteRNA Technologies | 18.5 M EUR |
| 2018-06-26 | Inthera Bioscience | Aglaia BioMedical Ventures investment in Series A - Inthera Bioscience | 4.7 M EUR |
| 2018-04-11 | Mimetas | Aglaia BioMedical Ventures investment in Series B - Mimetas | 20.5 M USD |
| 2017-05-31 | Inthera Bioscience | Aglaia BioMedical Ventures investment in Series A - Inthera Bioscience | 10.5 M CHF |
| 2017-01-19 | Cristal Therapeutics | Aglaia BioMedical Ventures investment in Venture Round - Cristal Therapeutics | 12.8 M EUR |
| 2017-01-09 | Macrophage Pharma | Aglaia BioMedical Ventures investment in Series A - Macrophage Pharma | 9 M GBP |
| 2015-12-15 | InteRNA Technologies | Aglaia BioMedical Ventures investment in Series A - InteRNA Technologies | 10.5 M USD |
| 2015-12-14 | Inthera Bioscience | Aglaia BioMedical Ventures investment in Seed Round - Inthera Bioscience | 3.4 M EUR |
| 2010-01-29 | Merus | Aglaia BioMedical Ventures investment in Series B - Merus | 21.7 M EUR |
More informations about "Aglaia BioMedical Ventures"
Aglaia Oncology Funds | Investing in the Fight Against Cancer
Jul 11, 2024 Aglaia is an oncology specialist investor which selects and matures early-stage breakthrough inventions that have the potential to transform cancer prevention, diagnosis and …See details»
Aglaia BioMedical Ventures - Crunchbase Company Profile
Aglaia is founded on the principle that the willingness to take risks on the very early stage ventures of today results in opportunities that may grow into the winning companies of …See details»
Aglaia BioMedical Ventures - Investments, Portfolio & Company …
Aglaia BioMedical Ventures has made 10 investments. Their most recent investment was on Oct 7, 2021, when Sapreme Technologies raisedSee details»
Aglaia BioMedical Ventures - Financial Details - Crunchbase
Aglaia BioMedical Ventures has raised a single venture fund, Aglaia Oncology Fund II. This fund was announced on Sep 18, 2014 and raised a total ofSee details»
Aglaia BioMedical Ventures - Profiles & Contacts - Crunchbase
Highlights Aglaia BioMedical Ventures has 1 current employee profile, Founder and Director Mark Krul.Aglaia BioMedical Ventures has 1 board member or advisor, Joost Ruitenberg.See details»
Aglaia Oncology Funds - LinkedIn
Aglaia is an investment fund fully focused on the fight against cancer and the development of improved anti-cancer drugs in particular. Aglaia has a proven ability to select and mature early …See details»
Aglaia BioMedical Ventures - News & Analysis - Crunchbase
Aglaia BioMedical Ventures Growth Score 1 Heat Score 1 Save Actions Aglaia is founded on the principle that the willingness to take risks on the very early stage ventures of today results in …See details»
Aglaia Biomedical Ventures - BioCentury Company Profiles - BCIQ
Aglaia Biomedical Ventures - BioCentury Company Profiles for the biopharma industrySee details»
Aglaia BioMedical Ventures - Company Profile & Staff Directory
Aglaia BioMedical Ventures is a company located in Bilthoven, Utrecht with 2 employees. Access Aglaia BioMedical Ventures's email format and Aglaia BioMedical Ventures staff directory for …See details»
Aglaia BioMedical Ventures - Funding, Financials, Valuation
Aglaia BioMedical Ventures has raised a single venture fund, Aglaia Oncology Fund II. This fund was announced on Sep 18, 2014 and raised a total ofSee details»
Aglaia - EU-Startups
Aglaia is committed to define the strategic directions of the companies it invests in in close collaboration with innovators and entrepreneurs. Aglaia brings hands …See details»
Aglaia BioMedical Ventures is based in Australia | Angels Partners
Aglaia BioMedical Ventures, also known as Aglaia Oncology Funds, is an investment firm that specializes in the oncology sector with a focus on financing and developing early-stage …See details»
Aglaia Biomedical Ventures Fund: Performance | PitchBook
General Information Description Aglaia Biomedical Ventures Fund is an early-stage venture capital fund managed by Aglaia Oncology Funds. The fund is located in Bilthoven, …See details»
Aglaia BioMedical Ventures company information, funding
Aglaia BioMedical Ventures, build biomedical companies in the field of oncology. Here you'll find information about their funding, investors and team.See details»
Biotech venture capital firm Aglaia launches ... - Aglaia Oncology …
Sep 18, 2014 Biotech venture capital firm Aglaia launches new $65 mln Oncology fund September 18, 2014 Bilthoven, the Netherlands, 18 September 2014 – Dutch venture …See details»
Aglaia Biomedical Ventures - Golden
Aglaia Biomedical Ventures Aglaia is an oncology specialist investor which selects and matures early-stage breakthrough inventions.See details»
Leslie W. Butler - MPH, #Epidemiologist, #Biomedical Indexer
MPH, #Epidemiologist, #Biomedical Indexer, #Toxic tort litigation, #Public Health #Pharmacovigilance · Pharmacovigilance Specialist. Experienced Biomedical Indexer with 20 …See details»
Leidos: Innovative Solutions through Information Technology ...
Leidos is an innovation company rapidly addressing the world's most vexing challenges in national security and health. Our 47,000 employees collaborate to create smarter technology …See details»
Valentina Aguilar - Patient Education Associate - LinkedIn
Biomedical Science Co-op Student at Toronto Metropolitan University · I always noticed that I found joy in helping those around me and enhancing my knowledge on the human body. …See details»
Angel and VC Investments - NJEDA
Access to capital is pivotal to the growth of emerging New Jersey innovation-focused companies. Garden State businesses continue to attract the capital they need to grow. Below is a …See details»